A contribution to the physiology of the perilymph. II. Cochlear and cerebral blood flow.
D000281:Administration, Intranasal; D000818:Animals; D002245:Carbon Dioxide / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology; D002560:Cerebrovascular Circulation; D003051:Cochlea / Q000098:blood supply*; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000008:administration & dosage / Q000494:pharmacology; D006168:Guinea Pigs; D006207:Half-Life; D007269:Injections, Intra-Arterial; D007274:Injections, Intraperitoneal; D007761:Labyrinthine Fluids / Q000378:metabolism / Q000502:physiology*; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology; D010208:Papaverine / Q000008:administration & dosage / Q000494:pharmacology; D010313:Partial Pressure; D012039:Regional Blood Flow / Q000187:drug effects; D013997:Time Factors
D002245:Carbon Dioxide; D010208:Papaverine; D009638:Norepinephrine; D004837:Epinephrine